Skip to search formSkip to main contentSkip to account menu

DuP 941

Known as: DuP-941 
National Institutes of Health

Related topics

Related topics

3 relations
BiantrazoleCI 941

Broader (1)

losoxantrone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
A multicenter phase II trial of losoxantrone (DuP-941) in hormone-refractory metastatic prostate cancer.
Our purpose in this study was to determine the efficacy and toxicity of losoxantrone (DuP-941), an anthrapyrazole, in patients… 
1997
1997
Laser chemotherapy of human carcinoma cells with three new anticancer drugs.
A new experimental therapy for squamous carcinoma was tested by sensitizing human tumor cells with light-sensitive anticancer… 
1996
1996
A comparison of methods for limited-sampling strategy design using data from a phase I trial of the anthrapyrazole DuP-941
Abstract The pharmacokinetics of a drug in individual patients can be estimated using plasma samples collected at a limited… 
1995
1995
Interstitial laser photochemotherapy with new anthrapyrazole drugs for the treatment of xenograft tumors.
Photodynamic therapy (PDT) with lasers and new dyes has gained popularity in recent years as a minimally invasive technique with… 
1993
1993
A phase II study of losoxantrone (dup 941) in advanced breast cancer
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)